SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-6.08 Cr | ₹7.28 Cr | ₹1.20 Cr | ₹-5.47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SHREE GANESH REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-6.08 Cr |
| Mar2024 | ₹7.28 Cr |
| Mar2020 | ₹1.20 Cr |
| Mar2019 | ₹-5.47 Cr |
How is Net Cash Inflow / Outflow of SHREE GANESH REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-6.08 Cr | Negative | |
| Mar2024 | ₹7.28 Cr | 505.66 | |
| Mar2020 | ₹1.20 Cr | Positive | |
| Mar2019 | ₹-5.47 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹856.4 Cr | -1.2% | 17.6% | 15.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -1.2% |
17.6% |
15.1% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses